These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 6280474

  • 1. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
    Muiesan G, Alicandri CL, Agabiti-Rosei E, Fariello R, Beschi M, Boni E, Castellano M, Moniti E, Muiesan L, Romanelli G, Zanielli A.
    Am J Cardiol; 1982 Apr 21; 49(6):1420-4. PubMed ID: 6280474
    [Abstract] [Full Text] [Related]

  • 2. Effects of captopril, an angiotensin-converting enzyme inhibitor, in normotensive sodium-replete volunteers.
    Shepherd AN, Campbell BC, Reid JL.
    J Cardiovasc Pharmacol; 1982 Apr 21; 4(3):381-7. PubMed ID: 6177933
    [Abstract] [Full Text] [Related]

  • 3. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J, Cody RJ, Laragh JH.
    Am J Cardiol; 1982 May 21; 49(7):1667-74. PubMed ID: 7044087
    [Abstract] [Full Text] [Related]

  • 4. Effects of a single administration of captopril on hemodynamics and serum angiotensin converting enzyme activity, plasma renin activity and plasma aldosterone concentration in hypertensive patients.
    Hashimoto H, Hiwada K, Kokubu T.
    Jpn Circ J; 1981 Feb 21; 45(2):176-80. PubMed ID: 6262543
    [Abstract] [Full Text] [Related]

  • 5. The effect of captopril and propranolol on the responses to posture and isometric exercise in patients with essential hypertension.
    Vandenburg MJ, Holly JM, Goodwin FJ, Sharman VL, Marsh FP.
    Eur J Clin Pharmacol; 1983 Feb 21; 25(6):721-8. PubMed ID: 6319152
    [Abstract] [Full Text] [Related]

  • 6. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C, Sánchez G, Boyer JL, Delmar M, Serrano PA.
    Arch Inst Cardiol Mex; 1982 Feb 21; 52(4):295-300. PubMed ID: 6291470
    [Abstract] [Full Text] [Related]

  • 7. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA, Drayer JI, Priest RT, Chen TC.
    Am J Nephrol; 1982 Feb 21; 2(1):6-11. PubMed ID: 6295161
    [Abstract] [Full Text] [Related]

  • 8. The effects of captopril on blood pressure in essential hypertensive patients with low or normal plasma renin activity. Interference with autonomic nervous system.
    Degli Esposti E, Chiarini C, Masi A, Santoro A, Sturani A, Umile A, Zuccalà A, Zucchelli P.
    Clin Exp Hypertens (1978); 1981 Feb 21; 3(3):439-54. PubMed ID: 7018859
    [Abstract] [Full Text] [Related]

  • 9. The effect of captopril on renal hemodynamics in hypertensive patients.
    Duchin KL, Willard DA.
    J Clin Pharmacol; 1984 Feb 21; 24(8-9):351-9. PubMed ID: 6384279
    [Abstract] [Full Text] [Related]

  • 10. Humoral and hemodynamic effects of increasing doses of captopril in patients with essential hypertension.
    Sassano P, Pedrinelli R, Magagna A, Abdel-Haq B, Salvetti A.
    Am J Cardiol; 1982 Apr 21; 49(6):1574-6. PubMed ID: 6280486
    [Abstract] [Full Text] [Related]

  • 11. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
    Turini GA, Waeber B, Brunner HR.
    Eur Heart J; 1983 Jan 21; 4 Suppl A():189-97. PubMed ID: 6301835
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hemodynamic and endocrine changes associated with captopril in diuretic-resistant hypertensive patients.
    Fujita T, Ando K, Noda H, Sato Y, Yamashita N, Yamashita K.
    Am J Med; 1982 Sep 21; 73(3):341-7. PubMed ID: 6751080
    [Abstract] [Full Text] [Related]

  • 14. Captopril withdrawal after chronic therapy.
    Vlasses PH, Koffer H, Ferguson RK, Green PJ, McElwain GE.
    Clin Exp Hypertens (1978); 1981 Sep 21; 3(5):929-37. PubMed ID: 7026198
    [Abstract] [Full Text] [Related]

  • 15. Hormonal responses to long-term converting enzyme inhibition in hypertensive patients.
    Ogihara T, Maruyama A, Hata T, Mikami H, Nakamaru M, Naka T, Ohde H, Kumahara Y.
    Clin Pharmacol Ther; 1981 Sep 21; 30(3):328-35. PubMed ID: 6268347
    [Abstract] [Full Text] [Related]

  • 16. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
    Silberbauer K, Punzengruber C, Sinzinger H.
    Cardiology; 1983 Sep 21; 70(6):297-307. PubMed ID: 6370431
    [Abstract] [Full Text] [Related]

  • 17. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
    Nishioka A, Kubo S, Hirota Y, Kawamura K, Takatsu T.
    Jpn Heart J; 1982 Jul 21; 23(4):527-44. PubMed ID: 6752473
    [Abstract] [Full Text] [Related]

  • 18. Participation of the renin-angiotensin system in the maintenance of blood pressure during changes in posture in patients with essential hypertension.
    Morganti A, Sala C, Turolo L, Palermo A, Zanchetti A.
    J Hypertens; 1985 Feb 21; 3(1):55-61. PubMed ID: 2987342
    [Abstract] [Full Text] [Related]

  • 19. Captopril modifies the hemodynamic and neuroendocrine responses to sodium nitroprusside in hypertensive patients.
    Clementi WA, Durst NL, McNay JL, Keeton TK.
    Hypertension; 1986 Mar 21; 8(3):229-37. PubMed ID: 3512428
    [Abstract] [Full Text] [Related]

  • 20. Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure.
    Kubo S, Nishioka A, Nishimura H, Kawamura K, Takatsu T.
    Clin Pharmacol Ther; 1984 Oct 21; 36(4):456-63. PubMed ID: 6206977
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.